| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2023―Nov―21 |
Corrigendum: An <i>in Vitro </i>Short-Term Treatment with Black Tea-Derived Theaflavins Reduced Infectivity of SARS-CoV-2 in Saliva |
Motohiko Ogawa, Mana Murae, Shuetsu Fukushi, Kohji Noguchi, Hideki Ebihara, Masayoshi Fukasawa |
| 2 |
[GO] |
2023―Okt―05 |
An <i>in Vitro</i> Short-Term Treatment with Black Tea-Derived Theaflavins Reduced Infectivity of SARS-CoV-2 in Saliva |
Motohiko Ogawa, Mana Murae, Shuetsu Fukushi, Kohji Noguchi, Hideki Ebihara, Masayoshi Fukasawa |
| 3 |
[GO] |
2023―Apr―06 |
Survey on Headache During COVID-19 Infection in People with Chronic Headache |
Masakazu Ishii, Ikumi Ito, Hirotaka Katoh |
| 4 |
[GO] |
2023―Jan―22 |
Inhibitory Effects of Olive-Derived Phytochemicals on SARS-CoV-2 3C-Like Protease (3CL<sup>pro</sup>) |
Yoshimitsu Kiriyama, Hiromi Nochi |
| 5 |
[GO] |
2022―Jul―11 |
Establishment of an Easy and Convenient Anti-SARS-CoV-2 Neutralizing Antibodies Test Flow Starting from Community Pharmacies: Expansion of Pharmacy Functions Suitable During the Novel Coronavirus Era |
Kazuyuki Niki, Kozo Tada, Katsumi Suezawa, Tomoko Kasashima, Shin Fujisue, Eri Seichi, Miki Nakahara, Yoshiko Ohara, Akiko Yoshida, Mikiko Ueda |
| 6 |
[GO] |
2021―Mai―25 |
Verification of MA-T Safety and Efficacy Against Pathogens Including SARS-CoV-2 |
Takekatsu Shibata, Ryuta Urakawa, Chikako Ono, Yukihiro Akeda, Takayoshi Sakai, Shigeto Hamaguchi, Kiyoto Takamori, Tsuyoshi Inoue, Kazunori Tomono, Kiyoshi Konishi, Yoshiharu Matsuura |
|
